OncoVerity
OncoVerity is a mission-driven biotechnology company dedicated to applying computational tools to clinical and biological data to develop therapies that improve outcomes for cancer patients. The company emphasizes innovation, collaboration, and a unique approach to cancer treatment, aiming to transform hope into reality for patients through advanced bioinformatics and multi-omics platforms.
Industries
Products
Anti-CD70 monoclonal antibody program (licensed clinical-stage candidate)
A clinical-stage monoclonal antibody program directed at CD70 being developed for acute myeloid leukemia and other oncology indications; being advanced in combination trials with hypomethylating agents and BCL-2 inhibitor regimens in elderly newly diagnosed AML.
Anti-CD70 monoclonal antibody program (licensed clinical-stage candidate)
A clinical-stage monoclonal antibody program directed at CD70 being developed for acute myeloid leukemia and other oncology indications; being advanced in combination trials with hypomethylating agents and BCL-2 inhibitor regimens in elderly newly diagnosed AML.
Services
Bioinformatics-driven target discovery
Identification of novel therapeutic targets in oncology using multi-omics data and computational analysis.
Clinical development and trial execution (Phase 1/2)
End-to-end early- to mid-stage oncology clinical trial execution including protocol management, enrollment and interim efficacy/safety reporting.
Regulatory strategy and submission support
Regulatory planning and preparation for IND/IDE and related regulatory interactions, and oversight of regulatory labeling and promotional review.
Clinical supply chain and serialization services
Design and management of clinical supply operations including forecasting, sourcing, logistics and implementation of serialization/track-and-trace systems across markets.
Quality systems and supplier management
Oversight of global quality systems, supplier management and support for product launch readiness including roles aligned with qualified/responsible person responsibilities.
Patient advocacy and medical affairs support
Development and management of patient advocacy, stakeholder engagement, medical information and medical communications to incorporate the patient perspective into development.
Bioinformatics-driven target discovery
Identification of novel therapeutic targets in oncology using multi-omics data and computational analysis.
Clinical development and trial execution (Phase 1/2)
End-to-end early- to mid-stage oncology clinical trial execution including protocol management, enrollment and interim efficacy/safety reporting.
Regulatory strategy and submission support
Regulatory planning and preparation for IND/IDE and related regulatory interactions, and oversight of regulatory labeling and promotional review.
Clinical supply chain and serialization services
Design and management of clinical supply operations including forecasting, sourcing, logistics and implementation of serialization/track-and-trace systems across markets.
Quality systems and supplier management
Oversight of global quality systems, supplier management and support for product launch readiness including roles aligned with qualified/responsible person responsibilities.
Patient advocacy and medical affairs support
Development and management of patient advocacy, stakeholder engagement, medical information and medical communications to incorporate the patient perspective into development.
Expertise Areas
- Clinical trial management
- Multi-omics bioinformatics and target discovery
- Single-cell multi-omics
- Regulatory strategy and submissions (IND/NDA/BLA types)
Key Technologies
- Multi-omics analysis
- Single-cell multi-omics
- Bioinformatics and computational analysis for target identification
- Clinical trial data management and reporting